BWM
ATRS

Baystate Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Baystate Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,397
Closed -$3K – 737
2017
Q4 		$3K Hold
1,397
– – ﹤0.01% 485
2017
Q3 		$5K Hold
1,397
– – ﹤0.01% 420
2017
Q2 		$5K Hold
1,397
– – ﹤0.01% 424
2017
Q1 		$4K Hold
1,397
– – ﹤0.01% 417
2016
Q4 		$3K Buy
+1,397
New +$2.66K ﹤0.01% 396
2013
Q3 		– Sell
-1,397
Closed -$6K – 247
2013
Q2 		$6K Buy
+1,397
New +$5.4K ﹤0.01% 217

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baystate Wealth Management's ATRS Position: Q1 2018 in Review

Baystate Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2018, closing a stake of 1,397 shares — an estimated $3K sold.

Baystate Wealth Management first reported a position in ATRS in Q2 2013 and held it in 6 quarters. The position peaked at $6K in Q2 2013. 102 funds tracked by Wall St. Rank hold ATRS as of Q1 2018.

  • Baystate Wealth Management reported no remaining Antares Pharma, Inc. position as of Q1 2018 after selling out during the quarter.
  • Baystate Wealth Management sold 1,397 Antares Pharma, Inc. shares in Q1 2018, an estimated $3K.
  • Baystate Wealth Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 6 quarters.
  • Baystate Wealth Management's Antares Pharma, Inc. position peaked at $6K in Q2 2013.
  • 102 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2018.

Based on Baystate Wealth Management's 13F filing for Q1 2018, filed 24 Apr 2018.